[Clinical Guidelines for Cancer Chemotherapy under COVID-19 in the World].
Gan To Kagaku Ryoho
; 48(8): 992-995, 2021 Aug.
Article
en Ja
| MEDLINE
| ID: mdl-34404063
ABSTRACT
A risk of COVID-19 infection for cancer patients is reported slightly high compared with general citizens. Among patients with cancer and COVID-19, severe illness and mortality is slightly high and associated with general risk factors and risk factors unique to patients with cancer. Cancer therapy should not be stopped or postponed under COVID-19 because cancer will be fatal disease if delaying or stopping cancer treatment. Clinical guidelines for cancer chemotherapy is discussed under COVID-19 in this article.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
COVID-19
/
Neoplasias
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Humans
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Año:
2021
Tipo del documento:
Article